Primary Care/Hospitalist
RSSArticles
-
Q Ask the Experts: Is tampon use risky for users of DMPA?
Is use of depot medroxyprogesterone acetate (DMPA, Depo-Provera, Pfizer, New York City) linked to risk of toxic shock syndrome? Contraceptive Technology Update Editorial Advisory Board member Felicia Stewart, MD, adjunct professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of California San Francisco and co-director of the Center for Reproductive Health Research & Policy, tackles this question. -
More research emerges on DMPA and bone health
New data from a long-term cohort study comparing bone mineral densities (BMD) in adult users and nonusers of the injectable contraceptive depot medroxyprogesterone acetate (DMPA, Depo-Provera, Pfizer, New York City) indicate that while bone mineral density declines in current DMPA users, it is followed by substantial recovery after discontinuation. -
Changes in store for sterilization method
The company responsible for developing the Essure non-incisional permanent birth control procedure is seeking approval from the Food and Drug Administration (FDA) to extend effectiveness data on the Essure product labeling. -
Oil of Lemon Eucalyptus as an Insect Repellent
Frost AC. Oil of lemon eucalyptus as an insect repellent. Altern Med Alert 2005;8(8):85-89. -
Treatment Alternatives for Chronic Hepatitis B Virus Infection: A Cost-Effectiveness Analysis
By Malcolm Robinson, MD, FACP, FACG Emeritus Clinical Professor of Medicine, University of Oklahoma College of Medicine, Oklahoma City, OK Dr. Robinson serves as a consultant for TAP, Pfizer, Janssen, Eisai, J&J-Merck, and Procter & Gamble, is on the speakers bureau of Janssen, Eli Lilly, Solvay, TAP, and Aventis, and does research for Forest Labs, Wyeth-Ayerst, AstraZeneca, and Centocor. -
Treatment of Tuberculosis and Latent Tuberculosis Infection
The treatment of pulmonary tuberculosis is divided into an initial phase of four drugs for two months.
-
Pharmacology Update Medroxyprogesterone Acetate Injection (depo-subQ provera 104)
By William T. Elliott, MD, FACP, and James Chan, PhD, PharmD Dr. Elliott is Chair, Formulary Committee, Northern California Kaiser Permanente; Associate Clinical Professor of Medicine, University of California, San Francisco; Dr. Chan is Pharmacy Quality and Outcomes Manager, Kaiser Permanente, Oakland, CA. Drs. Chan and Elliott report no financial relationships to this field of study. -
Autonomic Peripheral Neuropathy
By Norm Latov, MD Professor of Neurology and Neuroscience and Director of the Peripheral Neuropathy Center at Weill Medical College at Cornell University. Dr. Latov is a consultant for Quest Diagnostics and Talecris Inc., is a stockholder of Therapath LLC, and has royalties in Athena Diagnostics. Synopsis: The availability of sensitive and reproducible measures of autonomic function has improved physicians ability to diagnose these disorders. -
Etiology of Elevated Troponin Levels Other Than in Acute Coronary Syndromes
By Harold L. Karpman, MD Clinical Professor of Medicine, UCLA School of Medicine Dr. Karpman reports no financial relationship to this field of study. -
Clinical Briefs
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment Foot Small Muscle Atrophy Before the Detection of Clinical Neuropathy Statins and the Risk of Colorectal Cancer